Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium

Journal of Psychosomatic Research

Volumn 71, Issue 4, 2011, Pages 277-281

  Grover, Sandeep ^a   Kumar, Vineet ^a   Chakrabarti, Subho ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Atypical antipsychotics; Delirium; Efficacy; Olanzapine; Risperidone

Indexed keywords

HALOPERIDOL; OLANZAPINE; RISPERIDONE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONSTIPATION; DELIRIUM; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYPERSALIVATION; JAW DISEASE; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; ORTHOSTATIC DIZZINESS; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SCORING SYSTEM; SEDATION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SLEEP DISORDER; SOMNOLENCE; TONGUE DISEASE; TREATMENT OUTCOME; TREMOR;

EID: 80052649960     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2011.01.019     Document Type: Article

References (24)

1. American Psychiatric Association Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999, 156:1-20.
2. Lacasse H., Perreault M.M., Williamson D.R. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother 2006, 40:1966-1973.
3. Peritogiannis V., Stefanou E., Lixouriotis C., et al. Atypical antipsychotics in the treatment of delirium. Psychiatry Clin Neurosci 2009, 63:623-631.
4. Bourne R.S., Tayyeb A.T., Borthwick M., et al. Drug treatment of delirium: past, present and future. J Psychosomatic Res 2008, 65:273-282.
5. Kim J.Y., Jung I.K., Han C., et al. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 2005, 59:183-188.
6. Han C., Kim Y. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004, 45:297-301.
7. Skrobik Y., Bergeron N., Dumont M., et al. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intens Care Med 2004, 30:444-449.
8. Hu H., Deng W., Yang H. A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongging Med J 2004, 8:1234-1237.
9. Breitbart W., Marotta R., Platt M.M., et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996, 153:231-237.
10. Lee Y., Lee J., Rim H.D., Kim S.H., Chung U.S., Cho G.A., et al. A comparative study of haloperidol and quetiapine in the treatment of delirium: a preliminary randomized open label, flexible dose trial. Eur Neuropsychopharmacol 2006, 16(Suppl 4):S488-S489.
11. Lee K.U., Won W.Y., Lee H.K., Kweon Y.S., Lee C.T., Pae C.U., et al. Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol 2005, 20:311-314.
12. Devlin J.W., Roberts R.J., Fong J.J., Skrobik Y., Riker R.R., Hill N.S., et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010, 38:419-427.
13. Girard T.D., Pandharipande P.P., Carson S.S., Schmidt G.A., Wright P.E., Canonico A.E., et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010, 38:428-437. MIND Trial Investigators.
14. Kim SW, Yoo JA, Lee SY, Kim SY, Bae KY, Yang SJ, Kim JM, Shin IS, Yoon JS. Risperidone versus olanzapine for the treatment of delirium. Human Psychopharmacol 2010;25:298-302.
15. Grover S., Chakrabarti S., Shah R., Kumar V. A factor analytic study of the Delirium Rating Scale-Revised-98 in untreated patients with delirium. J Psychosomatic Res 2001, 70:473-478.
16. Trzepacz P.T., Mittal D., Torres R., et al. Validation of delirium rating scale revised-98: comparison to the delirium rating scale and cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001, 13:229-242.
17. Gonzalez M., Pablo J., Fuente E., et al. Instrument for detection of delirium in general hospitals: adaptation of the Confusion Assessment Method. Psychosomatics 2004, 45:426-431.
18. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975, 12:189-198.
19. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970, 212:11-19.
20. Guy W. ECDEU assessment manual for psychopharmacology, revised ed 1976, US Department of Health, Education, and Welfare, Washington, DC.
21. Lingjaerde O., Ahlfors U.G., Bech P., et al. The UKU side effect rating scale. A new comprehensive scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic treated patients. Acta Psychiatr Scand 1987, 334:1-100.
22. Grover S., Subodh B.N., Avasthi A., et al. Prevalence and clinical profile of delirium: a study from a tertiary care hospital in north India. Gen Hosp Psychiatry 2009, 31:25-29.
23. Liu C.Y., Juang Y.Y., Liang H.Y., et al. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004, 19:165-168.
24. Miyaji S., Yamamoto K., Hoshino S., et al. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry Clin Neurosci 2007, 61:275-282.